血清胱抑素C与女性冠心病及其严重程度的关系

Relationship between serum cystatin C and coronary heart disease and its severity in female patients

  • 摘要: 目的 探讨血清胱抑素C预测女性冠心病及其严重程度的临床价值。 方法 通过医院电子病历系统选择在心内科住院的经冠状动脉造影明确的冠心病患者90例设为冠心病组,另选择同期非冠心病患者90例设为非冠心病组。冠心病组分为急性冠状动脉综合征组58例和慢性冠状动脉疾病组32例,再以性别分男性、女性亚组。急性冠状动脉综合征组依据Gensini评分判定患者病变严重程度,分为高危组( > 80分)22例、中危组(50~80分)18例、低危组( < 50分)18例。根据不同组别的血清胱抑素C水平差异,评估血清胱抑素C与冠心病及其严重程度的关系。 结果 冠心病组的胱抑素C水平显著高于非冠心病组(P < 0.05), 而冠心病组中女性胱抑素C水平显著高于男性(P < 0.05), 非冠心病组中男性、女性血清胱抑素C水平比较,差异无统计学意义(P > 0.05); 急性冠状动脉综合征组的胱抑素C水平显著高于慢性冠状动脉疾病组(P < 0.05), 而急性冠状动脉综合征组中女性的胱抑素C水平显著高于男性(P < 0.05); Gensini评分高危组的胱抑素C水平显著高于中危组、低危组(P < 0.05), 中危组的胱抑素C水平显著高于低危组(P < 0.05), 且Gensini评分与胱抑素C水平呈正相关性(P < 0.01)。 结论 胱抑素C水平可作为预测冠心病患者病情严重程度的一个重要指标,女性冠心病患者的血清胱抑素C水平较男性高,且Gensini评分与胱抑素C水平有正相关性。

     

    Abstract: Objective To explore the clinical value of serum cystatin C in prediction of coronary heart disease and its severity in female patients. Methods Through the hospital electronic medical record system, totally 90 patients with coronary heart disease confirmed by coronary angiography were selected as coronary heart disease group, and 90 patients with non-coronary heart disease were selected as non-coronary heart disease group. The coronary heart disease group was divided into acute coronary syndrome group(n=58)and chronic coronary disease group(n=32)according to types of attack, and was also divided into male group and female group according to gender. According to the Gensini score, the patients in the acute coronary syndrome group were divided into high-risk group(more than 80 points, n=22), medium-risk group(50 to 80 points, n=18)and low-risk group(less than 50 points, n=18). According to the different levels of serum cystatin C in different groups, the relationship between serum cystatin C and coronary heart disease and its severity was evaluated. Results The level of cystatin C in the coronary heart disease group was significantly higher than that in the non-coronary heart disease group(P < 0.05), and the level of cystatin C in female patients with coronary heart disease was significantly higher than that in female patients(P < 0.05). In the non-coronary heart disease group, there was no significant difference in serum cystatin C between male and female patients(P > 0.05). The level of cystatin C in the acute coronary group was significantly higher - than that in the chronic coronary artery disease group(P < 0.05), and the level of cystatin C in female patients was significantly higher than that in male patients(P < 0.05). The level of cystatin C in the high-risk group based on Gensini score evaluation was significantly higher than that in the medium-risk and low-risk group(P < 0.05), and that in the medium-risk group was significantly higher than low-risk group(P < 0.05). There was a positive correlation between Gensini score and cystatin C level(P < 0.01). Conclusion Cystatin C can be used as an important indicator for prediction of the severity of coronary heart disease. At the same time, serum cystatin C level in women is higher than men, and Gensini score is positively correlated with cystatin C level.

     

/

返回文章
返回